These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 19116892

  • 1. PAMAM dendrimers as potential agents against fibrillation of alpha-synuclein, a Parkinson's disease-related protein.
    Rekas A, Lo V, Gadd GE, Cappai R, Yun SI.
    Macromol Biosci; 2009 Mar 10; 9(3):230-8. PubMed ID: 19116892
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phosphorus-containing dendrimers against α-synuclein fibril formation.
    Milowska K, Gabryelak T, Bryszewska M, Caminade AM, Majoral JP.
    Int J Biol Macromol; 2012 May 01; 50(4):1138-43. PubMed ID: 22353396
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Observation of multiple intermediates in alpha-synuclein fibril formation by singular value decomposition analysis.
    Kamiyoshihara T, Kojima M, Uéda K, Tashiro M, Shimotakahara S.
    Biochem Biophys Res Commun; 2007 Apr 06; 355(2):398-403. PubMed ID: 17300751
    [Abstract] [Full Text] [Related]

  • 6. The aggregation and fibrillation of alpha-synuclein.
    Fink AL.
    Acc Chem Res; 2006 Sep 06; 39(9):628-34. PubMed ID: 16981679
    [Abstract] [Full Text] [Related]

  • 7. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ, Choi MY, Im H.
    Biochem Biophys Res Commun; 2009 Aug 14; 386(1):165-9. PubMed ID: 19501571
    [Abstract] [Full Text] [Related]

  • 8. beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
    Kim YS, Lim D, Kim JY, Kang SJ, Kim YH, Im H.
    Biochem Biophys Res Commun; 2009 Oct 02; 387(4):682-7. PubMed ID: 19622344
    [Abstract] [Full Text] [Related]

  • 9. Trehalose inhibits fibrillation of A53T mutant alpha-synuclein and disaggregates existing fibrils.
    Yu WB, Jiang T, Lan DM, Lu JH, Yue ZY, Wang J, Zhou P.
    Arch Biochem Biophys; 2012 Jul 15; 523(2):144-50. PubMed ID: 22575388
    [Abstract] [Full Text] [Related]

  • 10. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
    Schnack C, Danzer KM, Hengerer B, Gillardon F.
    Neuroscience; 2008 Jul 17; 154(4):1450-7. PubMed ID: 18541383
    [Abstract] [Full Text] [Related]

  • 11. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C, Lee SJ.
    J Neurochem; 2008 Oct 17; 107(2):303-16. PubMed ID: 18691382
    [Abstract] [Full Text] [Related]

  • 12. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
    Lee JH, Lee IH, Choe YJ, Kang S, Kim HY, Gai WP, Hahn JS, Paik SR.
    Biochem J; 2009 Mar 01; 418(2):311-23. PubMed ID: 19007333
    [Abstract] [Full Text] [Related]

  • 13. Viologen-Phosphorus Dendrimers Inhibit α-Synuclein Fibrillation.
    Milowska K, Grochowina J, Katir N, El Kadib A, Majoral JP, Bryszewska M, Gabryelak T.
    Mol Pharm; 2013 Mar 04; 10(3):1131-7. PubMed ID: 23379345
    [Abstract] [Full Text] [Related]

  • 14. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease.
    Azeredo da Silveira S, Schneider BL, Cifuentes-Diaz C, Sage D, Abbas-Terki T, Iwatsubo T, Unser M, Aebischer P.
    Hum Mol Genet; 2009 Mar 01; 18(5):872-87. PubMed ID: 19074459
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease.
    Bharathi P, Nagabhushan P, Rao KS.
    Comput Biol Med; 2008 Oct 01; 38(10):1084-93. PubMed ID: 18823621
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of fibrillation process of alpha-synuclein at the initial stage.
    Tashiro M, Kojima M, Kihara H, Kasai K, Kamiyoshihara T, Uéda K, Shimotakahara S.
    Biochem Biophys Res Commun; 2008 May 09; 369(3):910-4. PubMed ID: 18329380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils.
    Li J, Zhu M, Rajamani S, Uversky VN, Fink AL.
    Chem Biol; 2004 Nov 09; 11(11):1513-21. PubMed ID: 15556002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.